DIAGNOSIS OF CELL PROLIFERATIVE DISEASES
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Dec 25, 2014
app pub date -
Dec 21, 2012
filing date -
Dec 21, 2011
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The method of the present disclosure is directed towards a method and a kit for diagnosing a cell proliferative disease. This method includes the following steps; gathering a sample from a subject, measuring the fibulin expression level or measuring the fibulin activity level in the sample, comparing the measured fibulin expression level or measured fibulin activity level to a baseline level of fibulin expression or activity and assigning the subject to a normal or abnormal group based on the measured fibulin expression level or activity level in the sample. The present disclosure is also directed towards a kit for diagnosing a cell proliferative disease. The kit includes a sampler, a measurer, a comparor and an assignor.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully